Subscribe To Our Free Newsletter |
Hot Stocks: Brokerage view on Torrent Pharma, RIL, Voltas and Paytm
Nomura maintained a buy rating on Torrent Pharma but raised the target to Rs 2199 from Rs 1838 earlier. The potential acquisition of Cipla will be a big deal and it makes strategic sense. The acquisition will require large debt and equity dilution.